The global cardiovascular device market is expected to reach $69.3 billion by 2022


   July 11 2017
According to a new market report published by Lucintel, the future of the global cardiovascular device market looks good with opportunities in public and private hospitals. The global cardiovascular device market is expected to reach an estimated $69.3 billion by 2022, and it is forecast to grow at a CAGR of 4.3% from 2017 to 2022. The major drivers for market growth are growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.

 This report has 112 figures/charts and 84 tables spread through 197 pages. For more detail on this report please click link http://www.lucintel.com/cardiovascular-device-market-2017-2022.aspx

The cardiac rhythm management (CRM), interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices are the main branches of global cardiovascular device market. On the basis of comprehensive research, Lucintel forecasts that the structural heart device, electrophysiology, cardiac assist device, and diagnostic & monitoring device segments are expected to show above average growth during the forecast period.

Download Free PDF Report Brochure here http://www.lucintel.com/rb/cardiovascular-device-market-2017-2022.aspx

Within the global cardiovascular device market, the CRM segment is expected to remain the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.

Early buyers will receive 10% free customization on this report.

By device type, the global cardiovascular device market is segmented into pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others. The defibrillator is the largest market mainly due to the development of technologically advanced defibrillators and rapid growth in the aging population with high risk of cardiovascular diseases.

North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.

APAC is expected to witness the highest growth over the forecast period due to growing health awareness, improved healthcare infrastructure along with an increasing spending capacity of the population in this region.

Emerging trends which have a direct impact on the dynamics of the industry include increasing demand of portable heart monitoring devices, rising adoption of transcatheter aortic valve replacement (TAVR) procedure, and increasing use of bioresorbable stents. Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are among the major suppliers of cardiovascular devices.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cardiovascular device market by type, device, and region, and has compiled a comprehensive research report entitled “Growth Opportunities in the Global Cardiovascular Device Market 2017-2022: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions.

Download free sample here http://www.lucintel.com/ds/cardiovascular-device-market-2017-2022.aspx

The study includes a forecast for the global cardiovascular device market by type, device, and region, as follows:

By Type [Value ($ Million) from 2011 to 2022]:


  • Cardiac Rhythm Management


  • Interventional Cardiac Devices


  • Peripheral Vascular Devices      


  • Cardiac Assist Devices


  • Structural Heart Devices


  • Cardiovascular Surgery


  • Electrophysiology                                                        


  • Diagnostic & Monitoring Devices                      


By Device [Value ($ Million) from 2011 to 2022]:


  • Pacemaker                                                                   


  • Defibrillator                                                                  


  • Stent                                                                            


  • Cardiac Catheter                                                           


  • Guidewire                                                                     


  • Heart Valve                              


  • ECG                            


  • Event Monitor               


  • Others                                                  


By Region [Value ($ Million) from 2011 to 2022]:


  • North America


    • United States




  • Europe


    • Germany


    • France


    • United Kingdom


    • Italy


    • Spain




  • ·       APAC


    • Japan


    • China


    • India




  • ROW


    • Brazil




For current press releases of Lucintel

This 197-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link http://www.lucintel.com/toc/cardiovascular-device-market-2017-2022.aspx  or   helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

For further information, visit www.lucintel.com

Connect with us on LinkedIn here https://www.linkedin.com/company/lucintel?trk=top_nav_home

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [44]
Chemical [100]
Composites & Advanced Materials [99]
Construction & Industrial [40]
Consumer and Retail [78]
Economic Analysis [86]
Energy & Utility [68]
Finance & Services [10]
Healthcare [23]
Media & Entertainment [16]
Metals & Mining [16]
Technology & Telecommunication [44]
Transportation [75]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Partnership between Jushi USA and Gray Construction ...
Armor Express Awarded Five-Year ID/IQ Hard Armor Contract from U.S. Customs and Border Protection...
Hyundai Files Patent for CFRP Front End...
Velocity Composites Signs Long Term Agreement ...
Johns Manville's Starrov 853 for LFT Reinforcements is Available in Americas and Europe ...

Follow us on